Evidence map›Paper›PMID 32043240›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2021

Hypermetabolism of the spleen or bone marrow is an additional albeit indirect sign of infective endocarditis at FDG-PET.

Caroline Boursier, Xavier Duval, Besma Mahida, Bruno Hoen, François Goehringer, Christine Selton-Suty, Elodie Chevalier, Véronique Roch, Zohra Lamiral, Aurélie Bourdon and 6 more

Registry-linked trialAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02287792 (Effect of 18-FDG PET/CT Imaging on Clinical Decision Making During the Acute Phase of Infective Endocarditis), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02287792 nacompletednot on this map

Effect of 18-FDG PET/CT Imaging on Clinical Decision Making During the Acute Phase of Infective Endocarditis: a Multicenter Prospective Impact Study

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2015 to 2017Enrolled150ConditionsInfective EndocarditisArms18-FDG PET/CT scan
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Innovations in Imaging:Current cardiology reports · 2024
    Review
  2. Review
  3. Article
  4. Real world experience of therapeutic monitoring of medically treated prosthetic valve infective endocarditis byJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. [Journal of personalized medicine · 2022
    Article
  9. Article
  10. Nuclear Imaging in Infective Endocarditis.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Caroline BoursierUniversité de Lorraine, 54000, Nancy, France. c.boursier@chru-nancy.fr.
Xavier DuvalUniversité Paris Diderot, INSERM, UMR 1137 (IAME), 75000, Paris, France.
Besma MahidaDepartment of Nuclear Medicine, AP-HP, Hôpital Bichat Claude Bernard, 75000, Paris, France.
Bruno HoenUniversité de Lorraine, 54000, Nancy, France.
François GoehringerDepartment of Infectious Diseases, CHRU-Nancy, 54000, Nancy, France.
Christine Selton-SutyDepartment of Cardiology, CHRU-Nancy, 54000, Nancy, France.
Elodie ChevalierDepartment of Nuclear Medicine and Nancyclotep Molecular Imaging Platform, CHRU-Nancy, 54000, Nancy, France.
Véronique RochDepartment of Nuclear Medicine and Nancyclotep Molecular Imaging Platform, CHRU-Nancy, 54000, Nancy, France.
Zohra LamiralUniversité de Lorraine, CHRU-Nancy, INSERM, CIC 1433, 54000, Nancy, France.
Aurélie BourdonDepartment of Nuclear Medicine, Montpellier University Hospital, 34000, Montpellier, France.
Nicolas PiriouDepartment of Nuclear Medicine, CHU de Nantes, 44000, Nantes, France.
Amandine PallardyDepartment of Nuclear Medicine, CHU de Nantes, 44000, Nantes, France.
Olivier MorelCHU-Besançon, Université de Franche-Comté, Service de Médecine Nucléaire, 25000, Besançon, France.
François RouzetDepartment of Nuclear Medicine, AP-HP, Hôpital Bichat Claude Bernard, 75000, Paris, France.
Pierre-Yves MarieUniversité de Lorraine, 54000, Nancy, France.
AEPEI-TEPvENDO Study Group
Centre Hospitalier Régional et Universitaire de Nancy · FRUniversité Claude Bernard Lyon 1 · FRCentre de Médecine Préventive · FRCentre Hospitalier Universitaire de Nantes · FRInserm · FRCentre d’Investigation Clinique Innovation Technologique de Nancy · FRUniversité de franche-comté · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed at determining the diagnostic implications of indirect signs of infection at FDG-PET-i.e., hypermetabolisms of the spleen and/or bone marrow (HSBM)-when documented in patients with known or suspected infective endocarditis (IE).

methodsHSBM were defined by higher mean standardized uptake values comparatively to that of the liver on FDG-PET images from patients with a high likelihood of IE and prospectively included in a multicenter study.

resultsAmong the 129 included patients, IE was ultimately deemed as definite in 88 cases. HSBM was a predictor of definite IE (P = 0.014; odds ratio (OR) 3.2), independently of the criterion of an abnormal cardiac FDG uptake (P = 0.0007; OR 9.68), and a definite IE was documented in 97% (29/30) of patients showing both HSBM and abnormal cardiac uptake, 78% (7/9) of patients with only abnormal cardiac uptake, 67% (42/63) of patients with only HSBM, and 37% (10/27) of patients with neither one.

conclusionIn this cohort with a high likelihood of IE, HSBM is an additional albeit indirect sign of IE, independently of the criterion of an abnormal cardiac uptake, and could reinforce the suspicion of IE in the absence of any other infectious, inflammatory, or malignant disease.

Indexed as

Fluorodeoxyglucose F18Positron-Emission TomographyRadiopharmaceuticalsAgedAged, 80 and overBone MarrowEndocarditis, BacterialFemaleHumansMaleMiddle AgedProspective StudiesSpleenFluorodeoxyglucose F18RadiopharmaceuticalsFDG-PETInfectionInfective endocarditisPETvalvular heart disease

Identifiers

PMID32043240
OpenAlexW3006385584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.